CA2390631A1 - Carboxamide-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions - Google Patents

Carboxamide-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions Download PDF

Info

Publication number
CA2390631A1
CA2390631A1 CA002390631A CA2390631A CA2390631A1 CA 2390631 A1 CA2390631 A1 CA 2390631A1 CA 002390631 A CA002390631 A CA 002390631A CA 2390631 A CA2390631 A CA 2390631A CA 2390631 A1 CA2390631 A1 CA 2390631A1
Authority
CA
Canada
Prior art keywords
carboxamide
pharmaceutical compositions
benzimidazole derivatives
preparing
processes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002390631A
Other languages
French (fr)
Other versions
CA2390631C (en
Inventor
Ralf Anderskewitz
Christine Braun
Hans Briem
Bernd Disse
Christoph Hoenke
Hans Michael Jennewein
Georg Speck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2390631A1 publication Critical patent/CA2390631A1/en
Application granted granted Critical
Publication of CA2390631C publication Critical patent/CA2390631C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/16—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Abstract

The invention relates to carboxamide-substituted benzimidazole derivatives of general formula (I) (see formula I) wherein the groups R1, R2, R3 and R4 may have the meanings given in the claims and in the specification, processes for preparing them and the use of carboxamide-substituted benzimidazole derivatives as pharmaceutical compositions, particularly as pharmaceutical compositions with a tryptase-inhibiting effect.
CA002390631A 1999-11-10 2000-11-08 Carboxamide-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions Expired - Fee Related CA2390631C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19953899.9 1999-11-10
DE19953899A DE19953899A1 (en) 1999-11-10 1999-11-10 Carboxamide-substituted benzimidazole derivatives, process for their preparation and their use as medicaments
PCT/EP2000/010996 WO2001034572A2 (en) 1999-11-10 2000-11-08 Carboxamide-substituted benzimidazol derivatives, method for the production thereof and their use as tryptase inhibitors

Publications (2)

Publication Number Publication Date
CA2390631A1 true CA2390631A1 (en) 2001-05-17
CA2390631C CA2390631C (en) 2009-01-13

Family

ID=7928443

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002390631A Expired - Fee Related CA2390631C (en) 1999-11-10 2000-11-08 Carboxamide-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions

Country Status (11)

Country Link
EP (1) EP1237877B1 (en)
JP (1) JP2003513959A (en)
AR (1) AR026423A1 (en)
AT (1) ATE300524T1 (en)
AU (1) AU2155901A (en)
CA (1) CA2390631C (en)
CO (1) CO5300519A1 (en)
DE (2) DE19953899A1 (en)
ES (1) ES2246916T3 (en)
MX (1) MXPA02004649A (en)
WO (1) WO2001034572A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6656956B2 (en) 2001-02-08 2003-12-02 Boehringer Ingelheim Pharma Kg Benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions
DE10105628A1 (en) * 2001-02-08 2002-08-22 Boehringer Ingelheim Pharma Benzimidazole derivatives, process for their preparation and their use as medicines
WO2003024451A1 (en) * 2001-09-08 2003-03-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg 2-(2-phenylethyl)-benzimidazole-5-carboxamide derivatives and their use as tryptase inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI20115A (en) * 1997-04-07 2000-06-30 Axys Pharmaceuticals, Inc. Compounds and compositions for treating diseases associated with serine protease, particularly tryptase, activity
JP2002502844A (en) * 1998-02-03 2002-01-29 ベーリンガー インゲルハイム ファルマ コマンディトゲゼルシャフト 5-membered heterocyclic fused benzo derivatives, their preparation and their use as pharmaceuticals
JP2000143635A (en) * 1998-06-10 2000-05-26 Takeda Chem Ind Ltd Arterialization inhibitor
DE19834751A1 (en) * 1998-08-01 2000-02-03 Boehringer Ingelheim Pharma Disubstituted bicyclic heterocycles, their preparation and their use as medicines
JP2000095767A (en) * 1998-09-28 2000-04-04 Takeda Chem Ind Ltd Antagonist for gonadotrophic hormone-releasing hormone
DE19939463A1 (en) * 1999-08-20 2001-02-22 Boehringer Ingelheim Pharma Tryptase inhibitors useful e.g. for treating inflammatory or allergic disease, arteriosclerosis or neoplasia, comprising new or known 2-phenethyl-benzimidazole-5-carboxamides
DE19945810A1 (en) * 1999-09-24 2001-03-29 Boehringer Ingelheim Pharma Substituted benzimidazole derivatives, process for their preparation and their use as medicaments

Also Published As

Publication number Publication date
ES2246916T3 (en) 2006-03-01
EP1237877B1 (en) 2005-07-27
ATE300524T1 (en) 2005-08-15
AU2155901A (en) 2001-06-06
EP1237877A2 (en) 2002-09-11
CO5300519A1 (en) 2003-07-31
WO2001034572A3 (en) 2001-10-11
AR026423A1 (en) 2003-02-12
JP2003513959A (en) 2003-04-15
DE19953899A1 (en) 2001-05-17
WO2001034572A2 (en) 2001-05-17
CA2390631C (en) 2009-01-13
MXPA02004649A (en) 2002-10-23
DE50010843D1 (en) 2005-09-01

Similar Documents

Publication Publication Date Title
CA2425560A1 (en) Anticholinergics, processes for preparing them and their use as pharmaceutical compositions
MY127144A (en) New anticholinergics which may be used as medicaments as well as processes for preparing them
CA2303498A1 (en) Dioxocyclopentyl hydroxamic acids
CA2400268A1 (en) Pyrrolopyrimidinone derivatives, process of preparation and use
MY137039A (en) Thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof
CA2238859A1 (en) Amino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them
CA2334773A1 (en) Benzothiepine-1,1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use
CA2327723A1 (en) Bicyclic hydroxamic acid derivatives
MY133479A (en) Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
GEP20043241B (en) Compounds for Treatment of Ischemia and Pharmaceutical Compositions Containing the Same
CA2475113A1 (en) Isothiazole derivatives useful as anticancer agents
CA2414095A1 (en) Novel compounds
CA2396720A1 (en) Thiazolyl amide derivatives
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
DE602004011966D1 (en) Heterocyclylverbindungen
YU56302A (en) 8,8a-dihydro-indeno/1,2-d/thiazol-derivatives, substituted in position 8a, a method for their production and their use as medicaments, e.g.anorectic agents
CA2382322A1 (en) Aminocarbonyl-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions
CA2286511A1 (en) Novel macrolide derivatives
MY133112A (en) 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use
CA2322195A1 (en) Novel diphenyl-substituted 5-ring-heterocycles, method for producing them and their use as medicaments
MXPA02004441A (en) Isoxazole derivatives to be used as phosphodiesterase vii inhibitors.
CA2188796A1 (en) Heterocyclylbenzonitriles
NZ515108A (en) Novel ribose-substituted aromatic amides, method for the production and use thereof as medicaments
CA2399377A1 (en) New positive allosteric ampa receptor modulators (paarm), processes for preparing them and their use as pharmaceutical compositions
HK1043117A1 (en) Polycyclic 2-amino-thiazole systems, method for the production thereof and medicament containing said compounds

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed